Lisa Tracy, Rn., Bsn. Email and Phone Number

• 2019 Presidents Club Winner, S1-7th, S2-1st, finishing overall 4th/32..• 2019 exceeded sales quota & finished with overall growth of 121% to plan.• 2019 Rookie of the Year.• Winner of the 2019 Growth Award for Exceeding the National Average accomplishing the highest growth in the Nation.

• Joined launch team of JETREA (Ocriplasmin), first in class intravitreal injection for the treatment of symptomatic vitreomacular adhesion (VMA) promoting to Retina Specialists in a 6-state territory: Iowa, Nebraska, Kansas, Missouri, Arkansas, Oklahoma,• National vial sales leader, Quarter 1-2014.• Ranked 2nd in nation for new JETREA injectors, Quarter 1-2014.• Ranked 1st in region for new enrollers to JETREA CARE (leading indicator for vial sales), Quarter 2-2014.• Worked closely with cross-functional partners (Reimbursement Business Managers, Director, Medical Sciences Liaisons), ensuring continued JETREA sales growth.• *Due to Company downsizing was released from my contract effective September 30, 2014.

 Nurse Educator responsible for launching AUBAGIO, an oral medication for Multiple Sclerosis.  My job included educating patients on Aubagio and the MS One to One patient support program to include: MOA, common S/E’s, co-pay programs, financial options, A/E reporting, coordinating with specialty Pharmacy’s, addressing any patient concerns and conducting regularly scheduled follow-up educational calls to patients and family members to determine drug adherence and tolerance. Participate in 24 hour on-call services. Proficient with Avaya phones system, GNS, Patient Plus, Word doc, Excel and Share Point. 4/2011 to 3/2012 Spectrum Pharmaceuticals – Irvine, CA Efficiently and successfully promoted Zevalin, a Radioimmunotherapy for B-cell non-Hodgkin’s lymphoma in a large geographical territory to include: South Dakota, Nebraska and Iowa. Worked with World Renowned Lymphoma Specialists: Julie Vose, James Armitage, Kelly McCaul and Brian Link. Due to realignment / organizational changes my job was eliminated on 3/15/2012 along with 17 other positions.

• Sales Representative launching FOLOTYN, the first FDA approved product used to treat patients with a rare hematological malignancy, Peripheral T-Cell Lymphoma (PTCL) in the relapsed refractory setting.• Responsible for the education of physicians, pharmacists and nurses in the disease state PTCL while including complete education on the package insert in a 2-state territory, IA and NE.• 2010- Excelled in sales obtaining a 110% to plan finishing with $286,750 in Folotyn sales• Successfully managing one of the nations nationally recognized Lymphoma Centers: The University of Nebraska Medical Center.

• Out of 1200 applications I was one of 18 initial hires as CTI’s Sales Force to launch Pixantrone for patients with relapsed or refractory Non-Hodgkin’s Lymphoma.• Mastered NHL disease state and treatment options.• Successfully covered a 4-state territory to include the states of IA, NE, MO and KS.  FDA denied Pixantrone approval – all sales representatives released April 15, 2010

• Ranked 4th in nation for territory growth (17.7%), 2009• Ranked in top 10% of nation for percent to plan (122.8%), 2009.• Successfully promoted Avastin across 4 tumor types in the treatments of non-small cell lung cancer, first and second line metastatic colorectal cancer and metastatic HER2- breast cancer, and relapsed glioblastoma.• Mastered the scientific and technical knowledge necessary to be successful selling a cutting- edge Monoclonal Antibody. • Successfully increased access to the challenging “No See” offices by utilizing personal contacts and creative marketing tactics.

• Hired as part of inaugural sales team to launch Macugen, a novel anti-VEGF intravitreal injection for the treatment of neovascular age-related macular degeneration• President’s Club winner, 2005• Ranked 4th in nation (out of 44), 2005 (launch year of Macugen)• Awarded Circle of Excellence membership due to strong sales performance and leadership• Successfully covered a 3-state territory to include, IA, NE and SD.• Utilized product knowledge, efficacy message and strong work ethic to drive territory sales results.

• President’s Club Award (top 15% in nation), 2003• Ranked 20th in the nation (out of 145), 2003 • Sales Representative of the month for the Hepatitis Division, April 2002, June 2003 and January 2004.• Ranked #1 in district (out of 11), 2003.• Ranked #2 in district (out of 11), 2002

• Responsible for the development of the referral process from Primary Care Physicians to treating Hepatitis C Gastroenterologist throughout the state of Nebraska.• Received National recognition for becoming the #1 accrual for “AGI Physician Awareness Programs.”• ***After 11 months of sales contract employment, was promoted to a full-time position with Schering-Plough after continued growth in overall sales.